budesonide inhalation (VR647) / Vectura  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
budesonide inhalation (VR647) / Vectura
2015-000353-20: Clinical study to evaluate the the efficacy and safety of two doses of nebulised budesonide delivered by the VR475 Inhalation System, in comparison to conventionally nebulised budesonide, in patients with uncontrolled asthma

Completed
3
702
Europe, RoW
Budesonide nebuliser suspension delivered via the VR475 Inhalation System, Budesonide nebuliser suspension delivered by PARI BOY® Inhalation System, VR475, Nebuliser suspension
Vectura Limited, Vectura Limited
Uncontrolled Asthma, Uncontrolled Asthma, Body processes [G] - Circulatory and Respiratory Physiological Phenomena [G09]
 
 

Download Options